Cargando…
Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model
Context: The cardiotoxic effect of selective cyclo-oxygenase-2 inhibitors is well known. While rofecoxib and valdecoxib have been withdrawn, celecoxib remains on the market. Folic acid, a naturally occurring vitamin, has been shown to reduce myocardial ischemia and post-reperfusion injury in rats. O...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130581/ https://www.ncbi.nlm.nih.gov/pubmed/28274156 http://dx.doi.org/10.1080/13880209.2017.1299768 |